This 2024 APA Annual Meeting poster estimated the prevalence of tardive dyskinesia in antipsychotic users in the US, and found rates ranging from 94.1-127.4 per 1000 antipsychotic users.

Tardive Dyskinesia, Huntington Disease Chorea Treatment Now Available

By Leah Kuntz

May 15th 2023

Deutetrabenazine extended-release tablets are now available.

New Tool for Assessing the Impact of Tardive Dyskinesia

By Leah Kuntz

February 23rd 2023

A new, easy-to-use scale might be able to help clinicians determine the impact of tardive dyskinesia on patient functioning.

...

Advertise

Editorial

Terms and Conditions

Do Not Sell My Personal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777